BLISSGVS vs SYNCOMF: Stock Comparison

BLISSGVS vs SYNCOM FORMU (I)Updated 2 Jul 26, 4:08 PM ISTNSE & company filings

BLISSGVS is the larger company by market capitalisation. BLISSGVS shows a higher dividend yield and faster revenue growth, while SYNCOM FORMU (I) shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 5; SYNCOMF leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSSYNCOMF

Valuation lens

What price are you paying?

Market CapContext only
₹7,678 Cr
₹1,833 Cr
P/E RatioSYNCOMF has the lower reading
56.25x
21.24x
P/B RatioSYNCOMF has the lower reading
6.42x
4.38x
EPSBLISSGVS has the higher reading
₹3.64
₹0.26
Book ValueContext only
₹116.14
₹4.41
Dividend YieldBLISSGVS has the higher reading
0.21%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLISSGVS is the larger company
₹7,678 Cr vs ₹1,833 Cr
P/E Ratio
SYNCOMF has a lower P/E
21.24x vs 56.25x
P/B Ratio
SYNCOMF has a lower P/B
4.38x vs 6.42x
EPS
BLISSGVS has higher earnings per share
₹3.64 vs ₹0.26
Dividend Yield
BLISSGVS has a higher dividend yield
0.21% vs 0%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs -9%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 68.8%
Qtr Sales Growth
SYNCOMF has stronger quarterly sales growth
-0.69% vs -22.41%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSSYNCOMF
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSSYNCOMF
Live Price₹527.1₹19.46
Day Change0.68%1.04%
Volume3.93 L91.48 L
52-Week High₹553₹22.59
52-Week Low₹118₹10.21
Distance from 52W High-4.68%-13.86%

Valuation

MetricBLISSGVSSYNCOMF
Market Cap₹7,678 Cr₹1,833 Cr
P/E Ratio56.25x21.24x
P/B Ratio6.42x4.38x
EPS₹3.64₹0.26
Book Value₹116.14₹4.41
Dividend Yield0.21%0%

Growth

MetricBLISSGVSSYNCOMF
Revenue Growth (TTM YoY)29.8%-9%
EPS Growth (TTM YoY)124.7%68.8%
Qtr Sales Growth-22.41%-0.69%
Qtr Profit Growth-24.83%-1.04%

Profitability & Leverage

MetricBLISSGVSSYNCOMF
ROE10.94%18.42%
ROCE11.94%18.57%
Net Margin13.93%15.63%
Operating Margin21.74%20.91%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSSYNCOMF
Promoter Holding35.01% 0.35 pp50.57%
FII Holding8.07% 2.38 pp0.35% 0.14 pp
DII Holding9.47% 4.43 pp0%
Public Holding47.45% 1.7 pp49.08% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and SYNCOM FORMU (I).

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.